IRIT ARBEL
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
DIRECTOR, EXECUTIVE OFFICER
DIRECTOR, EXECUTIVE OFFICER
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2023-08-11
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2022-11-04
D
BIOTECHNOLOGY
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2017-05-04
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
2015-01-08
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2014-06-19
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2014-04-25
D
OTHER
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
DECLINE TO DISCLOSE
Equity
2012-12-04
D/A
OTHER
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
DECLINE TO DISCLOSE
Equity
2012-07-30
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
NO REVENUES
Equity
2012-07-19

